Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Metastatic to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05464992
What this trial is testing

Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI

Who this might be right for
GliomaBrain Metastases
Centre Paul Strauss 800
Large-scale testing (Phase 3)Study completedNCT00083304
What this trial is testing

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

Who this might be right for
Breast CancerMetastases
Spectrum Pharmaceuticals, Inc 368
Testing effectiveness (Phase 2)Ended earlyNCT05746481
What this trial is testing

Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Liza Villaruz, MD 3
Not applicableStudy completedNCT03303365
What this trial is testing

Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence

Who this might be right for
Brain MetastasesAdult Solid Tumor
Juergen Debus 203
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07745257
What this trial is testing

Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases

Who this might be right for
HR-positive, HER2-negative Metastatic Breast Cancer With Brain Metastases
Sun Yat-sen University 40
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Post-approval studies (Phase 4)Looking for participantsNCT06072807
What this trial is testing

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Weill Medical College of Cornell University 20
Not applicableLooking for participantsNCT07175077
What this trial is testing

7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)

Who this might be right for
Small-cell Lung CancerBrain Metastases
University of Missouri-Columbia 20
Early research (Phase 1)Ended earlyNCT00892801
What this trial is testing

Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Vanderbilt-Ingram Cancer Center 5
Not applicableStudy completedNCT00028509
What this trial is testing

Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201

Who this might be right for
Long-term Effects Secondary to Cancer Therapy in ChildrenNeurotoxicity
Children's Oncology Group 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06835179
What this trial is testing

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

Who this might be right for
Unresectable Metastatic Colorectal CancerMicrosatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 28
Very early researchEnded earlyNCT00253461
What this trial is testing

11C Topotecan PET Imaging

Who this might be right for
Lung CancerMetastatic CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT01600742
What this trial is testing

Vorinostat and Concurrent Whole Brain Radiotherapy for Brain Metastasis

Who this might be right for
Brain Metastasis
National Taiwan University Hospital 4
Testing effectiveness (Phase 2)Study completedNCT01125085
What this trial is testing

131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors

Who this might be right for
Brain Metastases From Solid Tumors
Philogen S.p.A. 32
Early research (Phase 1)Study completedNCT03565367
What this trial is testing

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

Who this might be right for
Malignant Central Nervous System NeoplasmMetastatic Malignant Neoplasm in the Central Nervous System
Daniel M. Spielman 9
Not applicableStudy completedNCT07631611
What this trial is testing

Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients

Who this might be right for
Solid TumorsMetastatic Cancer to LiverMetastatic Cancer to the Bone+5 more
Wenlong Zhong, MD 938
Not applicableTemporarily pausedNCT05485038
What this trial is testing

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas

Who this might be right for
Gliomas BenignGlioma, MalignantMetastases to Brain
Sklifosovsky Institute of Emergency Care 72
Not applicableStudy completedNCT02054689
What this trial is testing

Fractionated Stereotactic Radiosurgery for Large Brain Metastases

Who this might be right for
Large Brain Mets
Steven Burton 20
Not applicableNot Yet RecruitingNCT07107035
What this trial is testing

Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer

Who this might be right for
AI (Artificial Intelligence)NSCLC Brain Metastasis
Fudan University 20,000
Testing effectiveness (Phase 2)WithdrawnNCT04406610
What this trial is testing

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

Who this might be right for
Glioma of BrainCAR-T Cell Immunotherapy
Fuda Cancer Hospital, Guangzhou
Next Page